Welcome to the leading edge of cancer diagnostics.

At OmniSeq®, our mission since 2015 has been simple: To help each cancer patient find and access the drug or trial that’s right for them. We do this through molecular sequencing and first-of-its-kind comprehensive immune profiling, as well as pharmaceutical services.


Through a collaboration with LabCorp®, we created and launched OmniSeq INSIGHT℠. This innovative tool – which is offered exclusively to U.S.-based physicians by Integrated Oncology, a member of the LabCorp Specialty Testing Group, and biopharmaceutical customers globally through Labcorp Drug Development – enables medical professionals to identify appropriate treatments specific to a patient’s cancer and immune profile.

OmniSeq INSIGHTSM  is a comprehensive genomic and immune profiling assay for all solid tumors.

Research Based

Breakthrough research, scientific expertise, and commitment to improving patient care define what OmniSeq® is today.

Patient Focused

OmniSeq CARES® specialists are available to discuss what OmniSeq testing can do for you and your treatment plan.


OmniSeq is proud to partner with LabCorp/Integrated Oncology to expand access to testing nationwide.